A new trading day began on Tuesday, with Insmed Inc (NASDAQ: INSM) stock price down -4.58% from the previous day of trading, before settling in for the closing price of $68.09. INSM’s price has ranged from $21.92 to $84.91 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 21.77% over the past five years. Meanwhile, its annual earnings per share averaged 5.35%. With a float of $176.82 million, this company’s outstanding shares have now reached $179.38 million.
Let’s look at the performance matrix of the company that is accounted for 1271 employees. In terms of profitability, gross margin is 75.73%, operating margin of -219.95%, and the pretax margin is -250.22%.
Insmed Inc (INSM) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Insmed Inc is 2.31%, while institutional ownership is 107.12%. The most recent insider transaction that took place on Apr 01 ’25, was worth 502,577. In this transaction Chair and CEO of this company sold 6,830 shares at a rate of $73.58, taking the stock ownership to the 233,924 shares. Before that another transaction happened on Apr 01 ’25, when Company’s Officer proposed sale 6,830 for $73.55, making the entire transaction worth $502,352.
Insmed Inc (INSM) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.37 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 5.35% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 50.65% during the next five years compared to -13.12% drop over the previous five years of trading.
Insmed Inc (NASDAQ: INSM) Trading Performance Indicators
Here are Insmed Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.12. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 32.48.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.59, a number that is poised to hit -1.35 in the next quarter and is forecasted to reach -3.82 in one year’s time.
Technical Analysis of Insmed Inc (INSM)
Insmed Inc (NASDAQ: INSM) saw its 5-day average volume 2.83 million, a positive change from its year-to-date volume of 1.93 million. As of the previous 9 days, the stock’s Stochastic %D was 14.05%. Additionally, its Average True Range was 3.64.
During the past 100 days, Insmed Inc’s (INSM) raw stochastic average was set at 14.82%, which indicates a significant increase from 4.51% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 38.37% in the past 14 days, which was lower than the 41.05% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $77.31, while its 200-day Moving Average is $73.76. Nevertheless, the first resistance level for the watch stands at $68.96 in the near term. At $72.94, the stock is likely to face the second major resistance level. The third major resistance level sits at $75.33. If the price goes on to break the first support level at $62.59, it is likely to go to the next support level at $60.20. The third support level lies at $56.22 if the price breaches the second support level.
Insmed Inc (NASDAQ: INSM) Key Stats
With a market capitalization of 11.81 billion, the company has a total of 180,999K Shares Outstanding. Currently, annual sales are 363,710 K while annual income is -913,770 K. The company’s previous quarter sales were 104,440 K while its latest quarter income was -235,550 K.
